Find the right fit for you - faster
Get tailored insights about working at Resilience (CA) in one quick step.
Resilience (CA) Snapshot
Resilience is your biomanufacturing innovation partner, leading the pursuit of novel medicines by revolutionizing how they’re made, funded, and scaled.
A career at Resilience is more than just a job – it’s an opportunity to change the future.
Resilience is a technology-focused biomanufacturing company that’s changing the way medicine is made. We’re building a sustainable network of high-tech, end-to-end manufacturing solutions to better withstand disruptive events, serve scientific discovery, and reach those in need.
The dawn of the golden age of biotech is here. There are dozens of new modalities being developed, including novel ways of killing cancer cells, gene editing to fix mutations, and single doses that can erase lifelong debilitating conditions. Decades of misalignment and under investment have left the biomanufacturing industry unable to capitalize on its own discoveries – and vulnerable to dynamics that disrupt the delivery of life-saving therapies.
Our purpose is to create the processes and platforms that will allow scientists to make their novel therapies quickly, safely, and at scale.
Resilience is a technology-focused biomanufacturing company that’s changing the way medicine is made. We’re building a sustainable network of high-tech, end-to-end manufacturing solutions to better withstand disruptive events, serve scientific discovery, and reach those in need.
The dawn of the golden age of biotech is here. There are dozens of new modalities being developed, including novel ways of killing cancer cells, gene editing to fix mutations, and single doses that can erase lifelong debilitating conditions. Decades of misalignment and under investment have left the biomanufacturing industry unable to capitalize on its own discoveries – and vulnerable to dynamics that disrupt the delivery of life-saving therapies.
Our purpose is to create the processes and platforms that will allow scientists to make their novel therapies quickly, safely, and at scale.
